Related Experiment Video
Updated: Jul 10, 2026
Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is
Aimee L Eggler1, Yan Luo, Richard B van Breemen
1The Center for Pharmaceutical Biotechnology, and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago 60607, USA.
Abstract:
Upregulation of cytoprotective and detoxifying enzyme expression by small molecules is emerging as an important means of preventing carcinogenesis as well as other diseases. A proposed target of these agents is the Kelch-like ECH-associated protein 1 (Keap1). The vast majority of these agents contain electrophilic moieties, which react with a subset of the 27 cysteines of human Keap1. Modification of these cysteines is proposed to result in nuclear accumulation of transcription factor NF-E2-related factor-2 (Nrf2), a Keap1 binding partner, leading to upregulation of cytoprotective enzymes. The electrophilic agent biotinylated iodoacetamide (BIA) has been used by different laboratories to determine the most reactive cysteines in human Keap1, and the different methods used have generated very different results. In particular, our group has found C151 of human Keap1 to be highly reactive, while others have not identified this cysteine as being even weakly reactive. Nevertheless, C151 is the only cysteine of Keap1 shown thus far in the cell environment to be required to sense chemopreventive agents. In this work, we show that the BIA-modified C151 tryptic peptide is reproducibly detected by our method. We also investigated the key differences in the methods that have been used to prepare the protein for modification by BIA. Removal of the reducing agent from Keap1 before the addition of BIA did not significantly change the modification pattern of Keap1. However, treatment of Keap1 using an ultracentrifugation device in one method resulted in approximately 99% of the protein remaining bound to the device at the time of BIA addition. In addition, the resulting pattern of cysteines identified as modified by BIA differed significantly from that obtained by our method. Notably, C151 was no longer detected as modified by BIA. We therefore recommend our method of Keap1 protein preparation for the detection of modified cysteines in proteomic studies.
Insights
This study clarifies how to best detect modifications on the Keap1 protein using biotinylated iodoacetamide (BIA). Researchers recommend a specific protein preparation method for accurate identification of reactive cysteines, crucial for understanding cytoprotective enzyme regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- Small molecules upregulate cytoprotective enzymes by targeting Kelch-like ECH-associated protein 1 (Keap1).
- Electrophilic agents modify Keap1 cysteines, leading to nuclear factor Nrf2 accumulation and enzyme expression.
- Discrepancies exist in identifying reactive cysteines in Keap1 using biotinylated iodoacetamide (BIA).
Purpose of the Study:
- To resolve conflicting results regarding reactive cysteine identification in human Keap1 using BIA.
- To establish a reproducible method for detecting BIA-modified cysteines in Keap1.
- To investigate how protein preparation methods influence BIA modification patterns.
Main Methods:
- Utilized biotinylated iodoacetamide (BIA) for cysteine modification of human Keap1.
- Employed a specific protein preparation protocol for BIA modification.
- Analyzed BIA-modified peptides using mass spectrometry.
- Compared results with methods involving ultracentrifugation and reducing agent removal.
Main Results:
- The BIA-modified C151 tryptic peptide of Keap1 was reproducibly detected using the developed method.
- Removing reducing agents did not significantly alter Keap1 modification patterns.
- Ultracentrifugation-based preparation led to altered BIA modification patterns, with C151 no longer detected.
- Significant differences in cysteine modification patterns were observed between methods.
Conclusions:
- The developed method reliably detects BIA-modified C151 in Keap1.
- Protein preparation protocols critically impact the identification of modified cysteines.
- Recommends a specific Keap1 preparation method for accurate cysteine modification detection in proteomic studies.
